Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin supplementation for fluid resuscitation in moderate/severe acute pancreatitis
ChiCTR2300068777Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Mar 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of albumin (human) and lactated ringer's solution in acute pancreatitis (AP) (2 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: Day 3 SIRS mitigation rate. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
albumin (human)lactated ringer's solution
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR2300068777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068777.